Terns Pharmaceuticals (TERN) EBT: 2020-2024
Historic EBT for Terns Pharmaceuticals (TERN) over the last 5 years, with Dec 2024 value amounting to -$89.0 million.
- Terns Pharmaceuticals' EBT fell 33.49% to -$21.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$90.0 million, marking a year-over-year decrease of 49.47%. This contributed to the annual value of -$89.0 million for FY2024, which is 1.12% up from last year.
- According to the latest figures from FY2024, Terns Pharmaceuticals' EBT is -$89.0 million, which was up 1.12% from -$90.0 million recorded in FY2023.
- Terns Pharmaceuticals' 5-year EBT high stood at -$40.9 million for FY2020, and its period low was -$90.0 million during FY2023.
- For the 3-year period, Terns Pharmaceuticals' EBT averaged around -$79.8 million, with its median value being -$89.0 million (2024).
- Per our database at Business Quant, Terns Pharmaceuticals' EBT crashed by 49.47% in 2023 and then grew by 1.12% in 2024.
- Yearly analysis of 5 years shows Terns Pharmaceuticals' EBT stood at -$40.9 million in 2020, then decreased by 21.48% to -$49.7 million in 2021, then decreased by 21.10% to -$60.2 million in 2022, then slumped by 49.47% to -$90.0 million in 2023, then grew by 1.12% to -$89.0 million in 2024.